Inhibiting NF-κB activity is crucial in addressing inflammatory reproductive disorders, such as polycystic ovary syndrome (PCOS), recurrent pregnancy loss, and infertility. The gene discussed is NFKB1; the disease is polycystic ovary syndrome.